KALA BIO, Inc.
KALA
$3.72
-$0.25-6.30%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/11/2025
-
TipRanks Financial Blog
4/10/2025
-
The Fly
4/9/2025
-
The Fly
4/8/2025
-
The Fly
4/2/2025
-
TipRanks Financial Blog
4/2/2025
-
The Fly
4/1/2025
-
TipRanks Financial Blog
3/31/2025
-
The Fly
3/31/2025
-
The Fly
3/31/2025
-
Globe Newswire
2/26/2025
-
Globe Newswire
2/12/2025
-
Globe Newswire
2/2/2025
-
MarketBeat
1/24/2025
-
TipRanks Financial Blog
1/24/2025
-
The Fly
1/8/2025
-
MarketBeat
1/1/2025
-
MarketBeat
12/30/2024
-
Globe Newswire
11/27/2024
-
Globe Newswire
11/15/2024
-
TipRanks Financial Blog
11/12/2024
-
The Fly
11/12/2024
-
Globe Newswire
9/25/2024
-
TipRanks Financial Blog
8/19/2024
-
The Fly
8/8/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 996 5252
Address
1167 Massachusetts Avenue
Arlington, MA 02476
Arlington, MA 02476
Country
Year Founded
Business Description
Sector
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company’s lead product...
more